Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Imaging Studies I: Kidney, Ureter, and Bladder Studies01:28

Imaging Studies I: Kidney, Ureter, and Bladder Studies

340
Kidney, Ureter, and Bladder (KUB) StudiesKidney, Ureter, and Bladder (KUB) studies are standard diagnostic imaging procedures used to assess the anatomy of the urinary system. They are commonly utilized for patients experiencing abdominal pain or urinary symptoms. By using a simple X-ray of the abdomen, KUB studies can reveal structural and pathological abnormalities within the kidneys, ureters, and bladder. These studies are particularly valuable in diagnosing kidney stones, urinary...
340
Predicting Molecular Geometry02:27

Predicting Molecular Geometry

45.7K
VSEPR Theory for Determination of Electron Pair Geometries
45.7K
Urinary Bladder01:23

Urinary Bladder

3.4K
The urinary bladder is a hollow, muscular sac that temporarily stores urine before it is expelled from the body. It can hold approximately 600 mL of urine prior to micturition. The bladder is retroperitoneal and located behind the pubic symphysis in the pelvic floor.
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
3.4K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

6.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.5K
Prediction Intervals01:03

Prediction Intervals

3.4K
The interval estimate of any variable is known as the prediction interval. It helps decide if a point estimate is dependable.
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y. 
3.4K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

779
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
779

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fascial Mild Urethral Sling or Artificial Urinary Sphincter in the Neurological Women Population, a Multicenter Study.

Neurourology and urodynamics·2026
Same author

Beyond Mankind, Self-Illusion and Medical Expertise of Artificial Intelligence in the Era of COVID-19.

Open forum infectious diseases·2026
Same author

Complications and causes of readmission following retropubic versus transobturator midurethral sling surgery in 88,880 patients.

The French journal of urology·2026
Same author

AI-Driven Patient Screening for Clinical Trials in Pancreatic Cancer: The PANCR-AI Pilot Retrospective Comparative Study.

JMIR cancer·2026
Same author

Sarcopenia measured by artificial intelligence as a predictor of overall survival in localized bladder cancer, a multicenter study.

BMC cancer·2025
Same author

Effects of a personalized or generic three-dimensional tumoral kidney model on patient experience and caregiver-patient interactions, before and after partial nephrectomy, a randomized trial (Rein 3D Print Personalize-UroCCR 114).

PloS one·2025

Related Experiment Video

Updated: Jan 29, 2026

Culture of Bladder Cancer Organoids as Precision Medicine Tools
08:39

Culture of Bladder Cancer Organoids as Precision Medicine Tools

Published on: December 28, 2021

5.4K

Sarcopenia Predicts Mortality in Bladder Cancer with Neoadjuvant Chemotherapy: A Multicenter Study.

Alice Pitout1, Charles Mazeaud1,2, Alicia Blondeau1

  • 1Department of Urology, CHRU de Nancy, 54500 Vandoeuvre -lès-Nancy, France.

Cancers
|January 28, 2026
PubMed
Summary
This summary is machine-generated.

Sarcopenia, a measure of muscle mass, is a significant predictor of mortality in bladder cancer patients undergoing neoadjuvant chemotherapy. This study highlights its prognostic value and compares different measurement thresholds for improved clinical assessment.

Keywords:
bladder cancerbody compositionchemotherapyneoadjuvantsarcopenia

More Related Videos

3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer
09:24

3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer

Published on: September 13, 2018

9.5K
An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

13.1K

Related Experiment Videos

Last Updated: Jan 29, 2026

Culture of Bladder Cancer Organoids as Precision Medicine Tools
08:39

Culture of Bladder Cancer Organoids as Precision Medicine Tools

Published on: December 28, 2021

5.4K
3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer
09:24

3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer

Published on: September 13, 2018

9.5K
An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

13.1K

Area of Science:

  • Oncology
  • Radiology
  • Geriatrics

Background:

  • Sarcopenia, assessed via CT scans, is a known negative prognostic factor in various cancers.
  • Its role in bladder cancer patients receiving neoadjuvant chemotherapy is not well-established.
  • This research investigates sarcopenia's prognostic impact on survival outcomes in this specific patient group.

Purpose of the Study:

  • To evaluate the prognostic significance of sarcopenia on survival in bladder cancer patients.
  • To compare different sarcopenia measurement thresholds and their impact on prognostic accuracy.
  • To assess sarcopenia's association with progression-free survival (PFS) and pathological complete response (pCR).

Main Methods:

  • Retrospective multicenter study of 74 invasive urothelial carcinoma patients treated with neoadjuvant chemotherapy and cystectomy (2015-2021).
  • Sarcopenia assessed using Skeletal Muscle Index on CT scans before chemotherapy (BC) and before surgery (BS).
  • Primary endpoint: overall survival. Secondary endpoints: PFS, pCR, treatment complications.

Main Results:

  • Sarcopenia prevalence was 27% BC and 39% BS.
  • Sarcopenia was significantly associated with increased all-cause mortality (HR 3.38-6.08, p=0.012-0.032) and shorter PFS.
  • Forty percent achieved pCR, 35% had recurrence; median PFS was 25 months.

Conclusions:

  • Sarcopenia is an independent and reproducible prognostic factor for mortality in bladder cancer patients.
  • The study provides the first comparison of sarcopenia threshold values at different time points (BC vs. BS).
  • Findings suggest incorporating sarcopenia assessment into clinical practice for risk stratification.